Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.

To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform. 

Displaying One Session

Public Health Oral Session
Session Type
Public Health Oral Session
Session Date
07/22/2020
Session Time
08:45 - 10:10
Room
Hall F

Session Webcast

Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

TAILORING TAILORED MESSAGES? EFFECTIVENESS OF TAILORED MESSAGES TO IMPROVE BEHAVIORAL INTENT TO ACCEPT HUMAN PAPILLOMAVIRUS (HPV) VACCINATION MAY BE MODERATED BY SOCIODEMOGRAPHIC FACTORS. (ID 913)

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

INFLUENZA VACCINE VISITS ARE AN UNDERUTILIZED AVENUE FOR INCREASING HUMAN PAPILLOMA VIRUS VACCINATION RATES: AN AAP PEDIATRIC RESEARCH IN OFFICE SETTINGS (PROS) NETWORK STUDY (ID 1159)

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN MANAGING THE RISK OF VACCINE HESITANCY IN A STUDY OF SINGLE-DOSE HPV VACCINATION (ID 1288)

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

UNDERSTANDING DATA SYSTEMS THAT ENABLE ASSESSMENT OF THE IMPACT OF HPV VACCINATION IN HIGH-INCOME COUNTRIES (ID 1331)

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

HPV VACCINE UPTAKE AND ASSOCIATED FACTORS IN ADULT WOMEN AGED UP TO 45 YEARS FROM 9 EUROPEAN COUNTRIES (COHEAHR-WP4 STUDY) (ID 1287)

Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

AFTER THE SUSPENSION OF THE PROACTIVE HPV VACCINE RECOMMENDATION BY THE JAPANESE GOVERNMENT; WHAT HAPPENED AND WHAT IS HAPPENING IN JAPAN? (ID 458)

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

THE LONG-TERM IMPACT AND CLINICAL OUTCOMES OF FEWER VERSUS STANDARD DOSES OF HUMAN PAPILLOMAVIRUS VACCINE IN THE UNITED STATES: A DATABASE STUDY - author request (ID 252)

Session Date
07/22/2020
Session Time
08:45 - 10:10
Room
Hall F
Session Type
Public Health Oral Session
Lecture Time
09:57 - 10:09

Webcast

[session]
[presentation]
[presenter]
Hide
Oral Session 5: VACCINATION II. Implementation, dissemination, and communication Hall F

Online Chat Q&A for this session is called: PUBLIC HEALTH ORAL SESSION 5: VACCINATION II. IMPLEMENTATION, DISSEMINATION, AND COMMUNICATION. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1820)

Session Date
07/22/2020
Session Time
08:45 - 10:10
Room
Hall F
Session Type
Public Health Oral Session
Lecture Time
10:09 - 10:09